SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 10 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $96,454 | -46.1% | 108,865 | -4.6% | 0.00% | – |
| Q3 2022 | $179,000 | -23.5% | 114,103 | -2.1% | 0.00% | – |
| Q2 2022 | $234,000 | -7.5% | 116,550 | +7.5% | 0.00% | – |
| Q1 2022 | $253,000 | -35.6% | 108,404 | +28.2% | 0.00% | – |
| Q4 2021 | $393,000 | -53.9% | 84,533 | -24.3% | 0.00% | -100.0% |
| Q3 2021 | $853,000 | -23.0% | 111,733 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $1,108,000 | +33.8% | 114,311 | +14.1% | 0.00% | 0.0% |
| Q1 2021 | $828,000 | -32.5% | 100,144 | -44.3% | 0.00% | -50.0% |
| Q4 2020 | $1,227,000 | -36.0% | 179,747 | +4.5% | 0.00% | -33.3% |
| Q3 2020 | $1,918,000 | +8.7% | 171,976 | -38.8% | 0.00% | 0.0% |
| Q2 2020 | $1,765,000 | +5986.2% | 281,046 | +1700.4% | 0.00% | – |
| Q1 2020 | $29,000 | – | 15,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |